Back
Celldex Therapeutics Stock Price Chart
Sponsored
CLDX
Sponsored
7 Proven Winners to Buy and Hold Forever
More Details here...
Sell
37
CLDX
Celldex Therapeutics
Last Price:
28.75
Seasonality Move:
12%
7 Day Trial
ALL ACCESS PASS
$
7
Multimillionaire Trader Reveals His #1 Gold Pick
Click here to learn more about this game-changing opportunity.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
Celldex Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.18 | Sell |
20-day SMA: | 33.26 | Sell |
50-day SMA: | 36.32 | Sell |
200-day SMA: | 38.43 | Sell |
8-day EMA: | 30.43 | Sell |
20-day EMA: | 32.79 | Sell |
50-day EMA: | 35.41 | Sell |
200-day EMA: | 36.7 | Sell |
Celldex Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 33.95 | Sell |
Chaikin Money Flow: | -85323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.86 - 40.3) | Sell |
Bollinger Bands (100): | (32.62 - 40.34) | Sell |
Celldex Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 29.72 while CLDX 8-day simple moving average is 30.18, which is a Sell signal.
- The stock price of CLDX is 29.72 while Celldex Therapeutics 20-day SMA is 33.26, which makes it a Sell.
- Celldex Therapeutics 50-day simple moving average is 36.32 while CLDX share price is 29.72, making it a Sell technically.
- CLDX stock price is 29.72 and Celldex Therapeutics 200-day simple moving average is 38.43, creating a Sell signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Sell
The current Celldex Therapeutics [CLDX] share price is $29.72. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
1.97B
Price in USD:
29.72
Share Volume:
780.55K
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 29.72 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 29.72 while CLDX 8-day exponential moving average is 30.43, which is a Sell signal.
- The stock price of CLDX is 29.72 while Celldex Therapeutics 20-day EMA is 32.79, which makes it a Sell.
- Celldex Therapeutics 50-day exponential moving average is 35.41 while CLDX share price is 29.72, making it a Sell technically.
- CLDX stock price is 29.72 and Celldex Therapeutics 200-day simple moving average is 36.70, creating a Sell signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and a decrease next year of $0.73 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is -2.44, suggesting Celldex Therapeutics is a Sell
- Celldex Therapeutics Relative Strength Index (RSI) is 33.95, which suggest Celldex Therapeutics is oversold
- The Bollinger Bands (25) for Celldex Therapeutics is (29.86 - 40.3), which suggest Celldex Therapeutics is a Sell
- The Bollinger Bands (100) for Celldex Therapeutics is (32.62 - 40.34), which suggest Celldex Therapeutics is a Sell
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.